|
|
|
|
|
Venture capitalists invested approximately $274 million nationally this week. This is a decrease of 2% from the prior week. A total of 26 companies raised venture capital. The average deal size was approximately $10.54 million. The largest geographic recipient of venture capital was California based companies to the tune of $176.45 million. This represented 64.44% of total venture financing. The semiconductor sector received the biggest chunk of venture capital, totaling $92 million. Early stage companies received 61.1% of total venture capital to the tune of $167.3 million.
|
|
|
|
|
A total of 40 equity financings in the United States took place this past week and the dollar amounts increased this reporting period by 10% to $573 million, compared to last week's $521 million.
Below are straightforward graphs so that you can quickly see how the equity investments in the United States were distributed by geography, industry and stage of development:
|
|
|
|
|
|
Note: States that received equity funding less than $20 million was included with the OTHER category.
California based companies raised 41% of the total $573 million in equity financings in the United States this past week. In line with our data analysis results, it was ascertained that the largest equity based financing in California was by Aviza Technology:
|
| Company Name |
Aviza Technology |
| Chief Executive Officer |
Mr. Jerauld "Jerry" Cutini |
| Business Description: |
semiconductor processing equipment. |
| Location: |
Scotts Valley, CA |
| Public or private |
Early privately held venture backed. |
| Financing: |
Raised $50 million in an initial financing. |
| Investors: |
VantagePoint Venture Partners |
|
|
|
|
|
|
Note: States that received equity funding less than $30 million was included with the OTHER category.
Biotech companies received 21% of the total $573 million in equity raised in the United States this period. Below is more information about the company with the largest equity financing in this sector:
|
| Company Name |
Cubist Pharmaceuticals, Inc. |
| Chief Executive Officer |
Mr. Michael W. Bonney |
| Business Description: |
develops drugs to treat bacteria and fungi |
| Location: |
Lexington, MA |
| Public or private |
Exchange: NASDAQ Ticker: CBST |
| Financing: |
Raised $90 million equity |
| Investors: |
Public offering of common stock plus underwriters excised options. Lead banker and Sole book runner is Morgan Stanley. |
|
|
|
|
|
|
As can be seen in the above pie chart, NASDAQ companies raised 47% of the equity in this reporting period. The largest NASDAQ equity transaction this period was completed by Cubist Pharmaceuticals, Inc. which is highlighted in the above section.
|
|
|
|
Below you will find a breakdown for this reporting period of significant debt and equity financings in the United States, Canada and internationally:
|
|
INVESTMENTS WEEK OF October 19th
|
| |
$ |
# |
| |
Millions |
Deals |
| Total Debt and Equity US |
1,571 |
48 |
| Total Debt and Equity Canada |
47 |
5 |
| Total Debt and Equity Int'l |
41 |
10 |
| Equity US |
573 |
40 |
| Equity Canada |
7 |
3 |
| Equity Int'l |
41 |
10 |
| Venture Capital US |
274 |
26 |
| Venture Capital Canada |
0 |
0 |
| Venture Capital Int'l |
34 |
9 |
|
NOTE: For a complete weekly detailed listing of newly funded companies, their funding amounts, names of the investor(s), key man information, general business content, as well as other highly valuable pieces of information. Using sales code VENTURE you can sing up at www.capitalhunter.com for the small price of $29 per quarter.
The Ultimate Goal of Capital Hunter's FUNDING WATCH free newsletter is to provide our readers with a valuable, current and accurate source of information about the private and public capital markets. WE WELCOME ANY AND ALL FEEDBACK ON HOW WE CAN MAKE THIS NEWSLETTER AND OUR SERVICE BETTER.
To be REMOVED from this free service, CLICK HERE. |
|
|
|
©2003 Capital Hunter, Inc. all rights reserved
|
